PK/PD of EA-230 During Endotoxemia

NCT02629874 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Endotoxemia
Systemic Inflammatory Response

Interventions

DRUG: EA-230
DRUG: Endotoxin
DRUG: Placebo

Sponsor

Radboud University Medical Center

Collaborators

[object Object]